Why scrub typhus damages blood vessels
Pathogenic Mechanisms of Vascular Dysfunction in Scrub Typhus
Researchers are exploring how scrub typhus harms blood vessels to find markers or treatments that could help people with severe infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-11146438 on NIH RePORTER |
What this research studies
This work uses mouse models that mimic human scrub typhus to study how the bacterium infects blood vessel cells and triggers damaging inflammation. Scientists are examining immune signals like TNFα and the Mincle receptor and monitoring blood-vessel stability proteins such as Tie2 to understand why vessels fail in severe disease. They compare infections with strains that cause lethal versus non-pathogenic outcomes to find shared markers of severe illness. The goal is to identify targets or tests that could eventually be used to help patients.
Who could benefit from this research
Good fit: Ideal candidates for any future human work would be people with confirmed or suspected severe scrub typhus or those at high risk of infection in endemic areas.
Not a fit: People without scrub typhus or those with only mild illness are unlikely to benefit directly from this basic research in the near term.
Why it matters
Potential benefit: If successful, the work could point to blood-vessel markers or drug targets that lead to tests or treatments for people with severe scrub typhus.
How similar studies have performed: Previous animal studies have reported immune signals (e.g., Mincle and TNFα) and vascular damage patterns, but translating these findings into proven human therapies remains unproven.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Soong, Lynn — University of Texas Med Br Galveston
- Study coordinator: Soong, Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.